Skip to main content
. 2024 Jun 27;20(8):5792–5799. doi: 10.1002/alz.13899

TABLE 3.

This table includes results from linear regression analysis of our cognitively healthy subgroup using motor performance as the predictor and biomarker burden in select ROIs as outcomes.

Linear regression analysis predicting each NIH motor assessment outcome by ROI biomarker burden for those cognitively healthy
Grip Walking speed Dexterity
Neurodegeneration β p β p β p
Precentral cortex 0.046 0.519 0.181 0.036 0.172 0.072
Parahippocampus 0.135 0.135 0.053 0.544 4.147 0.015
Entorhinal 0.053 0.462 0.111 0.212 0.283 0.003
Aβ burden
 Precentral cortex −0.082 0.508 −0.205 0.294 −0.025 0.897
 Parahippocampus −0.165 0.173 −0.195 0.278 −0.158 0.408
 Hippocampus −0.059 0.622 0.091 0.686 0.021 0.911
Tau burden
 Precentral cortex −0.120 0.321 −0.386 0.046 −0.065 0.754
 Parahippocampus −0.251 0.036 −0.195 0.276 −0.220 0.292
 Hippocampus −0.141 0.296 −0.173 0.440 −0.401 0.072

Note: All models were controlled for participant age and sex and corrected for multiple comparisons using the Benjamini–Hochberg (1995) procedure. The NIH motor assessment outcomes included the grip strength dynamometer, 2‐minute walking speed, and 9‐hole peg dexterity tests.

Abbreviations: Aβ, amyloid beta; NIH, National Institutes of Health; ROI, region of interest.